Cite
Nonmelanoma Skin Cancers After Kidney Transplant: Our 15 Years of Experience With Mammalian Target of Rapamycin Inhibitors
MLA
Gokalp, Okut, et al. “Nonmelanoma Skin Cancers After Kidney Transplant: Our 15 Years of Experience With Mammalian Target of Rapamycin Inhibitors.” Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation, vol. 15, no. Suppl 1, Mar. 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........ace9acafd1cd2f87fee63cee2a0c3f24&authtype=sso&custid=ns315887.
APA
Gokalp, O., Alper, A., Erhan, T., Cenk, S., Cem, T., & Adam, U. (2017). Nonmelanoma Skin Cancers After Kidney Transplant: Our 15 Years of Experience With Mammalian Target of Rapamycin Inhibitors. Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation, 15(Suppl 1).
Chicago
Gokalp, Okut, Alp Alper, Tatar Erhan, Simsek Cenk, Tugmen Cem, and Uslu Adam. 2017. “Nonmelanoma Skin Cancers After Kidney Transplant: Our 15 Years of Experience With Mammalian Target of Rapamycin Inhibitors.” Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation 15 (Suppl 1). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........ace9acafd1cd2f87fee63cee2a0c3f24&authtype=sso&custid=ns315887.